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ABSTRACT 
Metallothioneins (MTs) are low molecular weight proteins, characterized by a high cysteine 
content and the ability to coordinate large amounts of d10 metal ions, e.g. Zn(II), Cd(II), and 
Cu(I), in form of metal-thiolate clusters. Depending on intracellular conditions such as redox 
potential or metal ion concentrations, MTs can occur in various states ranging from the fully 
metal-loaded holo- to the metal-free apo-form. The Cys thiolate groups in the apo-form can be 
either reduced or be involved in disulfide bridges. 
Although oxidation-mediated Zn(II) release might be a possible mechanism for the 
regulation of Zn(II) availability by MTs, no concise information regarding the associated 
pathways and the structure of oxidized apo-MT forms is available. Using the well-studied Zn2γ-
Ec-1 domain of the wheat Zn6Ec-1 MT we attempt here to answer several question regarding the 
structure and biophysical properties of oxidized MT forms, such as: (1) does disulfide bond 
formation increases the stability against proteolysis, (2) is the overall peptide backbone fold 
similar for the holo- and the oxidized apo-MT form, and (3) are disulfide bridges specifically or 
randomly formed? 
Our investigations show that oxidation leads to three distinct disulfide bridges independently 
of the applied oxidation conditions and of the initial species used for oxidation, i.e., the apo- or 
the holo-form. In addition, the oxidized apo-form is as stable against proteolysis as Zn2γ-Ec-1, 
rendering the currently assumed degradation of oxidized MTs unlikely and suggesting a role of 
the oxidation process for the extension of protein lifetime in absence of sufficient amounts of 
metal ions.  
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INTRODUCTION 
Metallothioneins (MTs) are a class of small (up to 12 kDa) intracellular proteins widespread 
in all phyla of life. Their name is derived from the high content of cysteine residues in their 
primary amino acid sequences, which can reach up to 30% in the mammalian forms, and the 
associated large binding capacity for metal ions, mainly with d10 electron configuration. The 
metal ions are coordinated if form of metal-thiolate clusters and determine the function of MTs 
in essential metal ion metabolism of, depending on the organism, ZnII or CuI and in the 
detoxification of excess essential and also toxic non-essential metal ions such as HgII and CdII.1-4 
The cysteine thiolate groups have been also proposed to contribute to the protection against 
oxidative stress due to their high reactivity towards reactive oxygen (ROS) and nitrogen (RNS) 
species.5 It was shown that MTs are capable to react 300 times faster with hydroxyl radicals than 
reduced glutathione (GSH) and that expression of some MTs is up-regulated by H2O2, in this 
way protecting against DNA strand cleavage by OH•.6 The concomitant oxidation of the MT 
results in disulfide bridge formation. Generally, disulfide bridges in proteins can be formed via 
two mechanisms:7,8 Thiol-disulfide exchange reactions represent a one-electron oxidation and are 
observed, for example, during the oxidation of Cys thiolates with glutathione disulfide (GSSG). 
The second possibility involves the formation of a sulfenic acid intermediate, which is formally a 
two-electron oxidation of the involved sulfur atom and has been detected upon oxidation of Cys 
residues with oxygen or H2O2. The sulfenic acid intermediate is usually rather short lived and 
reacts rapidly with other Cys thiolate groups in the vicinity to form a disulfide bridge. 
Depending on the intracellular conditions such as redox potential and concentration of 
metal ions a given MT can adopt different states ranging from the fully metal-loaded and 
reduced holo-form to the metal-free apo-form, sometimes also denoted thionein (Figure 1). 
Fluorescent labeling of thiol groups in rat kidney and brain homogenates revealed that 
approximately 50% of the MTs present are in the apo-form. The value for rat liver is 27%.9 Such 
apo-forms have been suggested to be important for the buffering of the intracellular free ZnII ion 
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concentration.10 While MTs exist in their apo-forms directly after ribosomal synthesis and prior 
to post-translational metal ion-loading, the metal-free form can be also formed in the cell by 
demetalation, either via competition with other enzymes, e.g. zinc fingers,11,12 or chelators,13 or 
via oxidation by ROS and RNS (Figure 1).14 For rat liver (see above) it has been shown that 
actually one quarter of the apo-MT content is present in its oxidized state, i.e. 7% of the total MT 
content.15 
 
>>> insert Figure 1 here <<< 
 
Since the discovery of MTs, the main research focus has been on the biophysical and structural 
characterization of the holo-forms. Coordination of metal ions and formation of metal-thiolate 
clusters is assumed to be the critical factor for a defined three-dimensional structural fold as the 
unstructured peptide backbone wraps around the metal core.16,17 In absence of metal ions, 
reduced apo-MTs generally do not adopt compact structures and exist as a highly dynamic and 
flexible polypeptide chains. However, the extend of this absence of three-dimensional structure 
is still under discussion. Support for the existence of unstructured peptide chains was obtained by 
NMR and circular dichroism (CD) spectroscopy. The NMR spectra of reduced apo-γ-Ec-1 
(Figure S1, Supporting Information) show that all amide proton chemical shifts are located 
around 8-8.5 ppm, the region characteristic for random coil.18 CD spectra of a number of apo-
MTs reveal only one negative ellipticity band at 210 nm that originates from the natural chirality 
of amino acid residues in unfolded proteins.22, 23 Nevertheless, it cannot be entirely excluded that 
the CD signals indicative for secondary structural elements were not detected due to low 
ellipticity values or because of signal overlap with other transitions.24, 25 The presence of β-sheet 
structures was proposed for MTs that contain longer Cys-free amino acid stretches such as the 
plant MT1, MT2, and MT3 forms based on analyses with CD and IR spectroscopy.19 In 
particular, these β-sheet structures were retained even in the metal-free state. Such a preservation 
of structural features was also derived for the recombinant human MT-1a form upon partial and 
even complete removal of coordinated zinc ions based on molecular dynamics simulations and 
on the ionization pattern obtained by mass spectrometry and explained by stabilization through a 
hydrogen bond network.20 Hence taken together, there seems to be as much experimental 
evidence supporting the presence of structural features of some kind in apo-MT forms as there 
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are studies contradicting them. Nevertheless, it remains difficult to conceive that the observed 
unique and defined multidomain cluster structures, involving 20 Cys residues in the mammalian 
MTs, can be shaped starting solely from a random coiled peptide without any structural prefold. 
However, not only the folding process in presence of metal ions is of interest. Also the process 
and outcome of apo-MT oxidation is mostly unknown. A major open question is if oxidation 
results in a single defined structure with specifically formed disulfide bridges or if multiple 
oxidized structures with random disulfide bridge pattern are obtained. On the one hand, 
oxidation of an MT with a random coil structure is unlikely to produce a specific cystine 
connectivity pattern, except that disulfide bridges might be formed preferentially between Cys 
residues close in sequence to each other. On the other hand, a pre-folded apo-MT structure 
should provide a suitable scaffold for specific disulfide bridge linkages. The latter hypothesis 
was challenged by the following experiment. The β-domain of mouse Cd7MT, i.e. Cd3β-MT1, 
which forms a well-defined structure, was oxidized with NO and a NMR spectrum recorded.21 
As this spectrum did not reveal any signals, random disulfide bridge formation was concluded. 
Hence the lack of evidence for a distinct oxidized structure was taken as proof for the presence 
of a random structure in this case. Specific disulfide bridges were so far only described to occur 
intermolecularly in MT dimers, e.g. upon gradual oxidation of mouse Cd7MT-1 at aerobic 
conditions22 or in marine mussel MT1 after exposure to cadmium.23,24 
To analyze the disulfide bridge formation process upon oxidation in more detail, we chose 
the γ-domain of the wheat Ec-1 MT as a target. This plant MT shows high expression levels in 
germ cells during embryogenesis and is assumed to play a role in ZnII homeostasis.25 The holo-
form of wheat Ec-1, Zn6Ec-1, folds into two domains, the N-terminal Zn2γ-Ec-1 and the C-
terminal Zn4βE-Ec-1 domain, containing 6 and 11 Cys residues, respectively.
26-28 The 26 amino 
acids long γ-domain peptide is especially suited for this study as it features the smallest divalent 
metal-thiolate cluster possible, i.e. Zn2Cys6, and because the three-dimensional structure of the 
Zn2γ-Ec-1 form has been previously determined with solution NMR.
26 A special focus will be set 
on the following questions: (1) does formation of disulfide bonds increase the stability against 
chemical treatment and proteolysis, (2) is the overall fold of the peptide backbone similar in the 
metal cluster-containing holo- and the oxidized apo-MT form, and (3) does oxidation lead to 
specific or random formation of disulfide bridges? 
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RESULTS 
Analysis of condition for the oxidation of apo- and Zn2γ-Ec-1 
Oxidation of MTs results in the formation of disulfide bridges and hence is accompanied by 
metal ion release from the metal clusters. For in vitro studies, several oxidation agents can be 
used, which differ in oxidation potential and either stimulate or not disulfide exchange during the 
oxidation process, denoted as disulfide scrambling. The most frequently used oxidants for this 
purpose are nitric acid,21 hydrogen peroxide in presence or absence of Fe2+,29 xanthine oxidase,29 
5,5’-dithiobis(2-nitrobenzoic acid) (DTNB),30,31 and glutathione disulfide (GSSG).32 For the 
current study we selected two different oxidation agents. Hydrogen peroxide was chosen due to 
its large reduction potential of E0’ = 1.343 V (pH 7, 25°C) and hence high oxidation power, its 
stability, specificity towards oxidation of only cysteine and methionine, but not of any other 
amino acids,33 low absorptivity above 210 nm (Figure S2, Supporting Information), and its 
compatibility with the 2-PDS assay as well as with analysis by mass spectrometry. In addition, a 
GSH/GSSG mixture was used, which has a reduction potential that is closely similar to the one 
of the cysteine/cystine redox couple, i.e. E0’ = −0.24 V versus E0’ = −0.22 V (pH 7, 25°C).34 On 
the one hand, the GSH/GSSG redox couple has biological relevance as it is the main regulation 
system for the intracellular redox potential. On the other hand, the similarity of the redox 
potentials and the possibility to form intermediate mixed disulfides (between oxidized MT 
thiolates and oxidized glutathione) allows progression of thiol-disulfide exchange reactions 
during the oxidation process and hence might promote formation of the thermodynamically most 
favored disulfide-bridge arrangement.35 Equimolar mixtures (typically 2 mM each) of GSH and 
GSSG are often used for folding of Cys-rich proteins that contain high amounts of disulfide 
bridges in their native structures that need to be specifically formed for proper protein function. 
An example is the oxidative folding of cyclotides in vitro.36 For the present study the use of a 
GSH/GSSG mixture is limited to certain experiments due to several experimental drawbacks, i.e. 
GSH is not compatible with the 2-PDS assay that is used to determine the concentration of 
reduced Cys thiol groups, γ-Ec-1 and GSSG cannot be separated by SEC due to overlapping 
elution volumes, and the affinity of GSH for ZnII ions excludes its use in the metal ion 
competition experiments involving γ-Ec-1 and zincon. 
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Incubation of apo- or Zn2γ-Ec-1 in 2 mM H2O2 for 8 h leads to complete oxidation according 
to the 2-PDS assay (Table S3, Supporting Information) and mass spectrometry (Figure S3, 
Supporting Information). The MS data shows only one major species with a molecular weight of 
2454.8 Da corresponding to the oxidized apo-form with all six Cys residues involved in 
intramolecular disulfide bridges (Mr,calc = 2454.9 Da for oxidized and Mr,calc = 2461.0 Da for 
reduced apo-γ-Ec-1). Only minor signals for species with higher sulfur oxidation states were 
detected such as sulfenic (–SOH), sulfinic (–SO2H), or sulfonic acids (–SO3H).
37 Size exclusion 
chromatography (SEC) of oxidized apo-γ-Ec-1 gives a major elution peak corresponding to the 
monomeric protein and only small amounts of γ-Ec-1 multimers were formed, most probably via 
intermolecular disulfide bridges (Figure S4, Supporting Information).  
Also incubation of apo-γ-Ec-1 with a 2 mM GSH/GSSG mixture for 8 h under strictly 
anaerobic conditions results in completely oxidized apo-γ-Ec-1 according to the peak assignment 
after SEC and analysis with the 2-PDS assay (Figure S5, Supporting Information, Table S1, 
Supporting Information). In contrast, oxidation of Zn2γ-Ec-1 is incomplete under these conditions 
and one equivalent of Zn(II) is retained (Table S1, Supporting Information). Analysis of this 
sample with MS was performed at neutral pH to preserve metal ion binding, and mass peaks 
corresponding to Zn2-, Zn1-, as well as oxidized apo-γ-Ec-1 were observed (Figure S6A, 
Supporting Information). At acidic pH, and hence after metal ion release, mass data with isotopic 
resolution of the species can be collected and show signals originating from the reduced form as 
well as from species with one and two disulfide bridges. In addition, very low intensity mass 
peaks for the completely oxidized form with three disulfide bridges are observed (Figure S6B, 
Supporting Information). Note that these MS analyses are qualitative in nature and are not a 
reliable measure for species quantification. The partially oxidized Zn1γ-Ec-1 species will be 
discussed further and in more detail below (see ‘Assignment of disulfide bridge connectivities 
with tandem MS/MS’). The summary of all oxidation conditions used and the resulting species 
are depicted in Figure 2. 
 
>>> insert Figure 2 here <<< 
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Oxidation of Zn2γ-Ec-1 and Zn
II
 release followed by UV and CD spectroscopy 
The UV spectra of holo-MTs are dominated by the respective ligand-to-metal charge 
transfer (LMCT) bands centered, e.g., at 230 nm for thiolate-Zn(II) and at 250 nm for thiolate-
Cd(II) transitions with molar extinction values in the range of roughly 4500-5000 M−1 cm−1 per 
Zn-S or Cd-S transition. In contrast, the molar extinction of disulfide bonds is only weak, e.g. the 
spectrum of cystine (Figure S8, Supporting Information) shows a pH-independent band around 
245 nm with a molar absorptivity of approximately 360±10 M−1 cm−1 that tails up to 300 nm 
(ε280nm 124±10 M
−1 cm−1).38,39 Accordingly, the transitions of disulfide bonds can be masked by 
the LMCT bands of ZnII- and CdII-thioneins or theoretically also by transitions of aromatic 
amino acids. However, as the γ-Ec-1 domain, in contrast to most other plant MTs, is devoid of 
aromatic amino acids, the absorption at 280 nm can be used here to monitor disulfide bridge 
formation, which is another advantage of the chosen system. For the analysis of metal ion release 
and oxidation a 10 µM Zn2γ-Ec-1 solution was incubated with 2 mM H2O2 and spectra were 
recorded in the time range 0-350 min (Figure 3). A GSH/GSSG mixture cannot be used as 
oxidant in this experiment due to its absorption in the relevant spectral range and its interaction 
with Zn(II) ions.  
>>> insert Figure 3 here <<< 
 
The decrease of the LMCT band at 230 nm and the absorptivity increase of transitions 
originating from the disulfide bridges in the broad range of 255-310 nm clearly show the release 
of Zn(II) ions and the concomitant oxidation of the protein, which is complete after 
approximately 160 min (Figure 3B). While Zn(II) release follows an almost linear time-
dependence and 50% Zn(II) release is observed after 50 min, the formation of disulfide bridges 
shows a rather long lag-phase and only sets on at this time point (Figure 3C). This observation 
fits to a hypothetical Zn1-species in which the two non-coordinating cysteine sulfur atoms are in 
an oxidation state different from the –I oxidation state in a disulfide bridge (denoted with * in 
Figure 3C, species I) and hence do not absorb in the 255-310 nm wavelength range. One 
explanation would be the formation of cysteine sulfenic acid intermediates that subsequently 
comproportionate with cysteine thiol groups to disulfide bridges.40,41 It is also possible, that one 
or both of the Cys sulfur atoms are still reduced. Reduced Cys thiolates contribute to the 
absorption at 230 nm but only with roughly 10% of the absorptivity of thiolate-Zn(II) transitions.   
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75% ZnII release is reached after approximately 90 min, which is in agreement with a 1:1 
mixture of Zn1- (I) and apo-γ-Ec-1 species. As the ε280nm value at 90 min indicates on average the 
presence of 1-1.5 disulfide bridges (taking into account the low molar extinction value of 
disulfide bridges and hence the greater error range of the values), different mixtures of species 
are possible, for example a 1:1 mixture of species I and II or of I and III. Finally, after complete 
ZnII release also the maximum absorptivity value for the disulfide bridges is reached and hence a 
completely oxidized apo-γ-Ec-1 species (III) is obtained. 
In an alternative approach, the Zn(II) release in presence of 2 mM H2O2 was monitored with 
the Zn(II)-chelator zincon. The Zn(II)-zincon complex has a characteristic absorption at 620 nm 
with an extinction coefficient ε620nm of 19’450 M
−1 cm−1 under the experimental conditions 
applied (literature value 17'500 M−1 cm−1).42 Interestingly, Zn(II) release in presence of zincon is 
much slower (350 min compared to 160 min, Figure 4A) than without this chelator, the reason 
for this not being clear.  
Both experiments allow the calculation of the first order rate constant of Zn(II) release from 
the γ-Ec-1 domain using the following equation:
32,43 
start t
start end
A A
ln k t
A A
−
= ⋅
−
 (Eq. 1) 
 The respective plot of ln((Astart-At)/(Astart-Aend)) against the incubation time is depicted in Figure 
4B for the experiment with zincon, and rate constants for four different time ranges 
corresponding to the release of 25, 50, 75, and 100% Zn(II) are given in the figure legend as well 
as an average constant (kav) for the entire range. Each of the four constants is twice as large in 
the experiment without the chelator (Figure 3C; Figure S9, Supporting Information) and hence 
the entire process is slowed down in the presence of zincon and not just a just part of it. A very 
similar value of (2.88 ± 0.02) x 10-4 s-1 is obtained when Zn2Ec-1 is incubated with a mixture of 1 
mM GSH and 4.5 mM GSSG and metal ion release is quantified with the Zn(II)-chelator 4-(2-
pyridylazo)resorcin (PAR).32  
  
>>> insert Figure 4 here <<< 
 
Another method to follow the oxidation process is based on changes of the protein structure 
than can be monitored by CD spectroscopy. Generally, the far-UV range of protein CD spectra 
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up to 240 nm is dominated by the peptide bond as chromophore and hence this region is 
indicative for secondary structures such as α-helix and β-sheet but also for random coil 
structures that prevail in MTs. Bands in the near-UV range of 260-320 nm show usually far less 
than 1% of the ellipticity values observed for the bands in the far-UV region and originate from 
aromatic amino acids. Additional contributions in this range can arise from disulfide bridges 
resulting in a very broad and weak signal centered around 260 nm.44 Most MTs, including the 
wheat Ec-1 protein, are devoid of aromatic amino acids, however, in this protein class the metal-
thiolate clusters can act as additional chromophores. Typically, the corresponding CD bands are 
observed in the broad wavelength range around the position of the respective LMCT bands in the 
UV/Vis spectra, i.e. around 230 nm for Zn(II) and around 250 nm for Cd(II)-MTs.45,46 Figure 5 
depicts the spectra of reduced apo- as well as Zn2γ-Ec-1, and the differences arising from the 
overlapping contributions of the peptide backbone structure and the Zn2Cys6 cluster are clearly 
visible in the range of roughly 210-250 nm. Upon oxidation, the maxima at 250 and 225 nm in 
the spectrum of Zn2γ-Ec-1 that are attributed to the cluster disappear as expected. Oxidation of 
the apo-form leads to an ellipticity increase in the far-UV region and can be explained with 
decreased peptide backbone flexibility upon disulfide bridge formation. However, transitions 
below 210 nm in these measurements (grey box in Figure 5) are to be interpreted with caution 
due to saturation of the detector at the concentrations used. After 3 h identical spectra are 
obtained regardless if oxidation of apo- or Zn2γ-Ec-1 was performed, corroborating formation of 
identical completely oxidized, metal-free forms under both conditions. 
 
>>> insert Figure 5 here <<< 
 
Reduction of oxidized γ-Ec-1  
Mild oxidation of cysteines to the oxidation state –I as occurring in disulfide bridges is a 
reversible process in vivo. In plant cells reduction is achieved by the glutathione/glutaredoxin or 
the thioredoxin/thioredoxin reductase system and by the GSH/GSSG redox couple.47-50 In the 
absence of oxidative stress, GSH concentrations are generally distinctively higher than the GSSG 
concentrations ranging between 2-4 mM.51 Hence, for the reduction experiments of oxidized γ-
Ec-1 an intermediate concentration of 3 mM GSH was used. The oxidized γ-Ec-1 species were 
obtained in four different ways as described above: 
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sample 1: Zn2γ-Ec-1 + 2 mM H2O2 
sample 2: reduced apo-γ-Ec-1 + 2 mM H2O2 
sample 3: reduced apo-γ-Ec-1 + 2 mM GSH/GSSG 
sample 4: Zn2γ-Ec-1 + 2 mM GSH/GSSG 
As stated above, analyses after dialysis show that samples 1-3 are completely oxidized 
(Table S1, S3, Supporting Information), while sample 4 still contains one equivalent of Zn(II) 
and is only partially oxidized according to the PDS assay (Figure S5 Peak 1, Tables S1 and S3, 
Supporting Information) and MS measurements (Figure S6A, Supporting Information). Samples 
1-3 remained completely oxidized after 5 h of incubation with 3 mM GSH (Table S3, Supporting 
Information). For sample 4 a certain degree of reduction was observed in the MS spectra (Figure 
S10, Supporting Information). While the MS spectrum before reduction reveals a mixture of 
fully reduced apo-γ-Ec-1, species containing one or two intramolecular disulfide bridges and 
even low intensity signals for a species containing three disulfide bridges, the highest intensity 
signals after reduction originate from the fully reduced apo-γ-Ec-1 form and only low intensity 
signals for the species with one and two disulfide bridges are observed. A possible explanation, 
why only partially oxidized γ-Ec-1 can be re-reduced, might be the sterically restricted 
accessibility of cystines by the reductant in a compact oxidized structure. Further experiments 
with enzymatic reduction systems might provide more insight into the reduction process.  
 
Assignment of disulfide bridge connectivities with tandem MS/MS 
Analysis of fully oxidized γ-Ec-1 
The distribution pattern of the Cys residues in the γ-Ec-1 domain has a certain similarity to 
the one observed in cyclotides. Cyclotides are a class of small backbone cyclized proteins found 
mainly in plants that contain usually six Cys residues engaged in three disulfide bridges forming 
a motive denoted as cyclic cystine knot. The most well-known member of the cyclotide family is 
the kalata B1 protein.52 The amino acid alignment of the γ-Ec-1 sequence with a smaller 
cyclotide, the 34 amino acids long MCoTI-II protein from Momordica cochinchinensis is shown 
in Figure 6A and reveals even a certain sequence similarity.53 Upon oxidation, also the six Cys 
residues of the γ-Ec-1 domain form three intramolecular disulfide bridges as discussed above 
(Figure S3, Supporting Information). 
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To identify the disulfide-linked residues, the peptide fragments obtained after tryptic 
digestion of a fully oxidized γ-Ec-1 form were analyzed by tandem MS/MS spectrometry (a 
detailed evaluation can be found in the Supporting Information including Figures S11-S13, as 
well as Tables S4 and S5). The data show formation of exactly three specific intramolecular 
disulfide bridges (Figure 6B, C). While covalent bonds between residues Cys8 and Cys10 as well 
as Cys14 and Cys20 are unambiguously identified in multiple fragment ions, proof for the 
disulfide bridge involving Cys4 and Cys22 is limited due to its special position within the 
structure. Only one fragment ion, assigned to the disulfide bridged peptide fragments Gly1-Asp6 
and Cys22-Arg26 (found 1069.1 Da; calc. 1069.4 Da), can directly support this connectivity. 
Rather surprisingly, the same specific disulfide bridge pattern is observed when the reduced apo-
γ-Ec-1 form was used as starting compound for complete oxidation with H2O2 (Figures S14-S16, 
Supporting Information). 
 
>>> insert Figure 6 here <<< 
 
Analysis of partially oxidized Zn1γ-Ec-1 
In addition to the study with the fully oxidized apo-γ-Ec-1 domain, also the disulfide bridge 
pattern in the partially oxidized sample of the general composition Zn1γ-Ec-1 was investigated. 
This stoichiometry seems to represent a rather stable intermediate in the oxidation process as it 
can be obtained from Zn2γ-Ec-1 upon incubation with a 2 mM GSH/GSSG mixture for 8 h 
(Figure S6, Supporting Information, Table S1, S3, Supporting Information). For the analysis of 
the intermediate oxidation product(s) by MS, the partially oxidized Zn1γ-Ec-1 sample was 
prepared using 1.5 mM H2O2, because this oxidant, in contrast to a GSH/GSSG mixture, does 
not interfere with the measurement. To monitor and validate the correct stoichiometry of the 
partially oxidized sample, small amounts of the reaction mixture were taken at different time 
points during the oxidation process. The metal ion content of each sample was analyzed with F-
AAS after incubation with Chelex 100 resin, while the –SH content was directly determined 
with the 2-PDS assay, which is not influenced by H2O2 under the conditions used here (Table S6, 
Supporting Information). After 50 min of incubation a sample containing approximately 1.2 
equiv of ZnII and 4.7 reduced Cys residues per MT molecule was obtained. This sample was 
alkylated with iodoacetamide (IAA) to prevent further Cys oxidation during MS sample 
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preparation and analysis. In addition, the introduced acetamide groups can serve as “labels” to 
identify non-oxidized Cys residues in the spectra. The deconvoluted ESI-MS data (Figure S17, 
Supporting Information) shows species with zero, two, four, and even six modified Cys residues 
corresponding to a mixture of completely oxidized apo-γ-Ec-1, partially oxidized species with 
two and one disulfide bridge, as well as the completely reduced form. Subsequently, the mixture 
was digested with trypsin and analyzed by MALDI-MS/MS following the same procedure as for 
the fully oxidized apo-γ-Ec-1 form described above and in the Supplementary Information. 
Already the MS data of the tryptic digest (Figure S18, Supporting Information) give some 
indications about the possible Cys connectivity pattern. The peptide fragment Cys8-Arg21 that 
contains four Cys residues occurs both fully reduced and with one disulfide bridge (1508.6 and 
1392.5 Da). MS/MS data show distinctive fragment ions that support a linkage between Cys14 
and Cys20 and acetamide modified Cys8 and Cys10 residues (Figure 7, species Ib). In addition, 
lower intensity fragment ions corroborate a second species with a Cys8-Cys10 linkage as well as 
modified Cys14 and Cys20 residues (Figure 7, Ic; Figure S19, Supporting Information, Table S7, 
Supporting Information).  
Another mass can be assigned to the linked peptide fragments Cys8-Arg21 and Cys22-
Arg26 including one modified and hence reduced Cys residue (1869.7 Da; Figure S18, 
Supporting Information). The MS/MS data again clearly reveal the presence of a disulfide bridge 
between Cys14 and Cys20 (Figure S20, Supporting Information; Table S8, Supporting 
Information). If Cys22 is linked to Cys8 or Cys10 cannot be decided (Figure 7, IIb) as no 
additional signals corroborating either of the two possibilities are observed. 
The species at m/z 2111.7 (Figure S18, Supporting Information) originates from the peptide 
Gly1-Arg21 modified with three acetamide groups (calc. 2110.8 Da) and hence contains one 
intramolecular disulfide bridge. The MS/MS data (Figure S21, Supporting Information, Table 
S9, Supporting Information) corroborate a mixture of two species showing two different 
disulfide bridge connectivities, i.e. either between Cys4-Cys8 (Figure 7, Id) or between Cys14-
Cys20 (Ia).  
Two more tryptic digest fragments were analyzed by MS/MS: the ion at 1985.8 assigned to 
the peptide Cys8-Arg21 modified with three acetamide groups and linked to peptide Cys22-
Arg26 and the ion at 1995.7 Da originating from peptide Gly1-Arg21 modified with one 
acetamide group (Figure S18, Supporting Information). Due to their similar masses, the two 
Page 12 of 36
John Wiley & Sons, Inc.
Biopolymers: Peptide Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 13
peptide fragments had to be analyzed in the same measurement (Figure S22, Supporting 
Information, Table S10, Supporting Information), however, most fragment ions can be clearly 
distinguished. According to the MS/MS data, Cys14 and Cys20 in peptide Cys8-Arg21 are 
clearly reduced and accordingly the disulfide bridge to peptide Cys22-Arg26 must involve next 
to Cys22 either Cys8 or Cys10. However, only a single fragment ion unambiguously 
corroborates a linkage between Cys8 and Cys22 (Figure 7, Ie). Peptide Gly1-Arg21 contains two 
disulfide bridges, one of which is again formed between Cys14 and Cys20. For the second 
bridge, different fragment ions support either a linkage between Cys8 and Cys10 or between 
Cys4 and Cys8. Accordingly, there seems to be again a mixture of species differing in the second 
disulfide bridge (Figure 7, IIa).  
Summarizing, partial oxidation of the Zn2γ-Ec-1 form yields a mixture of species with zero, 
one, two and three disulfide bridges (Figure S17, Supporting Information). The species with two 
disulfide bridges (Figure 7, IIa,b) contain always one bridge between Cys14 and Cys20. The 
second bridge can be formed from Cys8 to Cys4, to Cys10, or to Cys22 or between Cys10 and 
Cys22. The species with one disulfide bridge (Figure 7, Ia-e) should all still possess the ability to 
coordinate one Zn(II) ion, but coordination of this Zn(II) ion is not restricted to a certain binding 
site. It should be noted, however, that partial oxidation of the protein most likely influences the 
binding site environments and hence metal binding abilities and affinities cannot be compared to 
the binding sites in the fully reduced protein. The single disulfide bridge is either formed 
between Cys14 and Cys20 (species Ia, Ib) or involving Cys8 with Cys4, Cys10, or Cys22 (Ic-e). 
In Ie also a bridge between Cys10 and Cys22 is feasible. 
 
>>> insert Figure 7 here <<< 
 
Stability against proteolytic digestion 
The main cellular mechanisms for the removal of dysfunctional or redundant proteins is 
proteolysis. To analyze the stability of the different γ-Ec-1 forms against (limited) proteolytic 
digestion, the reduced and oxidized apo-forms as well as the Zn2γ-Ec-1 form were incubated with 
proteinase K. Although this protease is not of plant origin, it is well-suited for a general 
comparison of the stabilities as the γ-Ec-1 domain contains an intermediate number of potential 
proteinase K cleavage sites (Figure 8A). In addition, the protease is rather stable and active at 
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physiological pH, which allows also the study of the Zn(II)-containing form under the same 
conditions. After digestion, the resulting mixtures were analyzed and purified by SEC in 10 mM 
ammonium acetate buffer, pH 7.5 (Figure 8C, D), and further analysed by mass spectrometry.  
 
>>> insert Figure 8 here <<< 
 
The size exclusion chromatograms show identical retention volumes of the Zn2γ-Ec-1 form 
before and after digestion (Figure 8B). This alone does not exclude partial hydrolysis of the 
peptide backbone as cleaved peptide fragments could be still connected by the intact metal-
thiolate cluster.27,54 However, MS measurements performed at acidic pH (Figure S23, Supporting 
Information) solely reveal mass data for the full-length domain including species with cleaved C-
terminal residues. In contrast, the backbone of the reduced apo-γ-Ec-1 form was cleaved in 
several positions and consequently the elution volume is shifted considerably towards volumes 
for smaller peptide fragments (Figure 8C). These two experiments, i.e. digestion of the folded 
metal-thiolate cluster containing form versus digestion of the presumably unfolded reduced apo-
protein, demonstrate distinctly that the protein fold and hence the accessibility of cleavage sites 
have a strong influence on the cleavage efficiency and consequently on the stability of a given 
protein towards proteolytic digestion.  
Analysis of oxidized apo-γ-Ec-1 with SEC reveals a larger elution volume than observed for 
the reduced apo- and Zn2-forms suggesting a more compact structure. Nevertheless, deduction of 
a regular fold with NMR spectroscopy was, in contrast to studies with the Zn2γ-Ec-1 form, not 
possible. The fragments observed by MS after digestion (Figure S23, Supporting Information) 
originate mainly from the non-cleaved full-length peptide with only some C-terminal amino 
acids cleaved as similarly observed for the metal-thiolate cluster containing form (Figure 8C). 
Hence the oxidized apo-form is distinctively more stable against proteolytic digestion than the 
reduced apo-form, and in this respect very similar to the holo-form.  
 
DISCUSSION 
The high Cys content of MTs is the prerequisite for the typical metal-thiolate cluster 
formation with d10 transition metal ions. While these clusters have a high thermodynamic 
stability, the low redox potential of the metal bound thiolate groups makes the ligands 
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susceptible to oxidation by rather mild oxidants and under oxidative stress conditions, a process 
that is accompanied by metal ion release and the formation of disulfide bridges.40, 63-65 This 
oxidation sensitivity let to the proposal of a potential role of MTs in cellular redox buffering. 
Despite the fact that apparently up to 50% of the MT molecules within a cell can be present in 
the oxidized apo-state, very little is known about the structure and properties of apo-MTs. The 
purpose of this work was thus to perform a case study with the γ-Ec-1 domain, which hosts the 
smallest divalent metal-thiolate cluster feasible, i.e. Zn2Cys6, focusing on the structural aspects 
of the corresponding oxidized species.  
Analysis of the partially oxidized Zn1γ-Ec-1 sample neither shows a preferentially formed 
disulfide bridge nor the specific release of Zn(II) from one of the two binding sites. While the 
two disulfide bridges Cys8-Cys10 and Cys14-Cys20 were detected both in the partially oxidized 
Zn1γ-Ec-1 sample as well as in the fully oxidized apo-form, also other connectivities involving 
Cys4, Cys8, Cys10, and Cys22 were observed in the partially oxidized sample and hence a 
certain rearrangement of the disulfide bridges must occur upon full oxidation. Overall, the 
analysis allows the general conclusion that the oxidation sensitivities of the six Cys residues are 
apparently quite similar. 
In the fully oxidized γ-domain exclusive formation of exactly three distinct disulfide bridges 
is observed. This is surprising in light of the results with the partially oxidized protein and even 
more when considering that the same bridges were observed regardless if oxidation was 
performed with the Zn2- or the reduced apo-form and independent of the oxidation agent used. 
To the best of our knowledge, this is the first example of such a high degree of specificity in 
disulfide bridge formation in a given MT. The observed disulfide bridge pattern can be 
reasonably explained for the prefolded Zn2-form as all bridges are formed between Cys residues 
that were initially coordinating to the same metal ion and hence were close in space to each other 
before oxidation. This applies in particular to the bridge between Cys4 and Cys22, and hence 
between residues that are located at opposite ends of the amino acid sequence. Reduced apo-MTs 
are however generally viewed as intrinsically unstructured proteins and, while disulfide bridges 
between neighboring Cys residues, i.e. Cys8-Cys10 and Cys 14-Cys20, are easily perceivable, 
the observed Cys4-Cys22 bridge is highly unusual. One hypothesis could be that the preferred 
formation of the two disulfide bridges Cys8-Cys10 and Cys14-Cys20 (be it because there are 
rather close in sequence or because there are other attractive forces between residues in this area) 
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also brings the peptide ends close in space to enable formation of the third bridge between Cys4 
and Cys22. Certainly the question remains, why Cys8-Cys10 and Cys14-Cys20 are specifically 
formed and no bridges between Cys4-Cys8, Cys10-Cys14 and/or Cys20-Cys22 are observed, 
which are also close to each other in the sequence. It can be further hypothesized that at least for 
the γ-Ec-1 domain, the correct three-dimensional fold might not strictly depend on metal ion 
coordination and hence metal-thiolate cluster formation. While the tetrahedral tetrathiolate 
coordination of Zn(II) ions leads to structural restraints between four Cys residues, each disulfide 
bridge connects just two Cys, and this might be already enough to allow the peptide chain to 
“find” its thermodynamic minimum for a folded structure in the folding landscape. Hence both, 
metal ion binding and oxidation, might both lead to the same overall structure, that is however 
more compact in the oxidized state due to the shorter SS bonds compared to Zn(II)-S bonds. 
Additional support for this view, i.e. that also less constraints can lead to the “correct” structure, 
comes from the observation that some MTs that preferentially coordinate divalent metal ions 
such as Zn(II) and Cd(II) are also able to coordinate isostoichiometric amounts of Cu(I) or Hg(II) 
ions that prefer tri- or only dithiolate coordination environments. In the resulting species a 
specific cluster structure is preserved according to the UV spectra that changes only upon 
addition of a metal ion excess.19,55,56 Hence, it can be proposed that in these MTs the peptide 
structure is preserved to a certain extent although the more strict structural constraint of the 
tetrathiolate coordination was lost.    
Considering the possible in vivo function and further fate of oxidized MT species it is worth 
to notice that the oxidized apo-γ-Ec-1 form seems to have a comparable stability against 
proteolysis as the metal loaded form, while reduced apo-γ-Ec-1 is rapidly digested. Hence it is 
reasonable to doubt the proposed cellular degradation of oxidized MTs and it should be rather 
assumed that oxidation might play a protective role leading to extended protein lifetimes. This 
view also moves a re-reduction mechanism of oxidized MTs into the realms of possibility.  
Nevertheless, all experiments presented here were performed in vitro. Future studies should 
aim to elucidate the redox state of MTs in vivo in dependence of the cellular redox state or the 
presence of oxidizing agents in the growth media. Certainly, whenever possible it should be also 
considered that in living systems enzymatic isomerization of disulfide bridges as well as enzyme 
assisted oxidative protein folding can occur,57 which could also not be taken into account in the 
present study. 
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MATERIALS AND METHODS 
Chemicals and reagents 
Tris(hydroxymethyl)aminomethane hydrochloride (Tris-HCl) and isopropyl β-D-
thiogalactopyranoside (IPTG) were obtained from Biosolve (Chemie Brunschwig AG, 
Switzerland), Chelex® 100 resin from Bio-Rad (Switzerland), Luria-Bertani (LB) media used for 
Escherichia coli expression from Carl Roth AG (Switzerland), tris(2-carboxyethyl)phosphine 
(TCEP) from Fluorochem (Chemie Brunschwig AG), Tritirachium album proteinase K from 
Qbiogene (MP Biomedicals, Switzerland), trypsin from Roche Diagnostics (Mannheim, 
Germany), acetonitrile (ACN) from Merck (Switzerland), and reduced L-glutathione (GSH) from 
Carl Roth AG (Switzerland). All other reagents, including iodoacetamide (IAA), trifluoracetic 
acid (TFA), and the MALDI matrices α-cyano-4-hydroxycinamic acid (CHCA) and 2-
(hydroxyphenylazo) benzoic acid (HBPA), were purchased in ACS grade from Sigma-Aldrich or 
Fluka (Switzerland). 
 
Purification of the γ-Ec-1 domain 
The wheat γ-Ec-1 domain was overexpressed in form of its GST-fusion protein and purified 
as previously described including removal of the GST-tag with thrombin.26 Complete reduction 
of Cys residues was assured by treatment with 30 mM TCEP in 10 mM Tris-HCl buffer, pH 3, 
for 20 min followed by size-exclusion chromatography (SEC) in 10 mM HCl (HiLoad 16/600 
Superdex 30 pg column, GE Healthcare). After quantification of thiol groups with 2,2′-
dithiodipyridine (2-PDS assay)58 the γ-Ec-1 domain was stored at -80 
°C for future use. For all 
following procedures special care was taken to exclude any traces of oxygen. Accordingly, all 
solutions were degassed under vacuum and saturated with argon. Wherever possible, 
experiments were performed in a Type B Vinyl Anaerobic Chamber (Coy Lab, USA) equipped 
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with a palladium catalyst and operated with a 5% hydrogen/95% nitrogen gas mix. For the 
spectroscopic measurements septum-sealed cuvettes (Hellma AG, Switzerland) were used. 
 
Preparation of fully oxidized γ-Ec-1 
The pH of an oxygen-free solution of 30-50 µM completely reduced apo-γ-Ec-1 in 10 mM 
HCl was adjusted to 7.5 with ammonium acetate (10 mM final buffer concentration). Then, 
depending on the downstream experiment, either a GSH/GSSG mixture (2 mM final 
concentration each) or H2O2 (2 mM final) was added. After overnight incubation at room 
temperature low molecular weight components such as H2O2, GHS, GSSG, and Zn
2+ ions were 
removed either by SEC for the samples containing GSH/GSSG or by dialysis for the samples 
containing just H2O2 as oxidant. Complete oxidation was verified with the 2-PDS assay.  
For the oxidation experiments starting from the Zn2γ-Ec-1 form, the fully metal ion-loaded 
peptide was prepared by addition of 2.1 equivalents of Zn(II) ions to reduced apo-γ-Ec-1 in 10 
mM HCl followed by addition of ammonium acetate buffer (10 mM final) and pH adjustment 
with NaOH to 7.5. The Zn(II) excess was removed by dialysis against 10 mM ammonium 
acetate, pH 7.5, using a Tube-O-DialyzerTM device with a molecular weight cut-off of 1 kDa (G-
Biosciences, Socochim SA, Savigny, Switzerland). Oxidation was again performed overnight in 
two different ways: Either with 2 mM H2O2 followed by dialysis against 10 mM ammonium 
acetate, pH 7.5 (this sample was further used for MS analysis of the disulfide connectivity 
assignment), or with a 2 mM GSH/GSSG mixture followed by a SEC purification step (Superdex 
Peptide 10/300 GL column, GE HealthCare). The degree of Cys oxidation and Zn(II) release was 
determined with the 2-PDS assay and flame atomic absorption spectroscopy (F-AAS), 
respectively. While the sample obtained by oxidation with H2O2 is completely oxidized, 
oxidation with the GSH/GSSG mixture leads to a sample with a Zn(II):γ-Ec-1 stoichiometry of 
1:1. 
 
Zn(II) release under oxidative conditions 
Zn(II)-release was studied in two different ways, either with UV spectroscopy based on the 
decreasing absorptivity of the thiolate-to-Zn(II) charge transfer band at 230 nm or by monitoring 
the increase of the absorptivity at 620 nm arising from the formed Zn(II)-zincon complex.  
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For the first experiment, a solution of 10 µM Zn2γ-Ec-1 in 10 mM Tris-HCl, 10 mM NaCl, 
pH 7.5 was mixed with 2 mM (final concentration) H2O2 followed by immediate acquisition of 
UV spectra in the range 200-600 nm up to 350 min using a Cary 100 spectrophotometer (Agilent 
Technologies, Switzerland). 
For the second experiment, 100 µM 2-carboxy-2-hydroxy-5-sulfoformazylbenzene (zincon) 
was added to a solution of 10 µM Zn2γ-Ec-1 in 10 mM Tris-HCl, 10 mM NaCl, pH 7.5, and the 
mixture incubated with 2 mM (final concentration) H2O2. Zn(II) release was monitored at 620 
nm up to 830 min using a Cary 100 spectrophotometer.  
 
Proteinase K cleavage experiments 
To compare the proteolytic stability of Zn2γ-Ec-1, reduced apo-γ-Ec-1, and oxidized apo-γ-
Ec-1, a 40 µM solution each was incubated with T. album proteinase K in a molar ratio of 5:1 for 
30 min at 27 °C in a buffer containing 50 mM Tris-HCl, pH 8, and 10 mM CaCl2. Subsequently, 
the mixture was analyzed and separated by SEC using a Superdex Peptide 10/300 GL column 
(GE Healthcare) in 10 mM ammonium acetate buffer, pH 7.5, and a flow rate of 0.5 ml min-1. 
Fractions containing the γ-Ec-1 domain or its fragments were collected, combined, and analyzed 
by ESI-MS. 
 
Reduction of (partially) oxidized γ-Ec-1 with GSH 
Samples of the (partially) oxidized γ-Ec-1 domain were either prepared from apo- or Zn2γ-Ec-1 
using GSSH/GSH or H2O2 as oxidative reagents as described above and the released metal ions 
were removed by dialysis. From these four different preparations, only the one obtained from 
Zn2γ-Ec-1 by oxidation with the GSH/GSSG mixture still contained one equivalent of Zn
II. 
To analyze the reversibility of MT oxidation, 3 mM (final concentration) GSH was added to each 
of the four solutions of (partially) oxidized γ-Ec-1 and the mixtures were incubated for 5 h under 
strictly anaerobic conditions. Subsequent dialysis against 10 mM ammonium hydrogencarbonate, 
pH 7.5, was performed within the anaerobic chamber using vacuum degassed and argon 
saturated solutions. The total MT concentration in each sample was determined from its 
absorption at 205 nm with the Scopes method which uses an average extinction coefficient of 31 
L g -1 cm-1 for a protein without tyrosine or tryptophan residues.59 Multiplied by the molar mass 
of γ-Ec-1 (2461.7 g mol
-1) this results into ε205 = 76’312.7 M
-1 cm-1, which agrees well with the 
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value experimentally determined for a sample of oxidized γ-Ec-1 of known concentration, i.e. 
76’315 M-1 cm-1. The concentration of reduced –SH groups was again determined with the 2-
PDS assay, and the concentration of remaining Zn(II) ions in the samples generated from Zn2γ-
Ec-1 was measured with F-AAS.  
 
Circular dichroism measurements 
CD spectra were measured on a Jasco J-715 spectropolarimeter (Jasco, Japan) over a 
spectral range of 200-350 nm with a scan speed of 50 nm min-1 and accumulation of three 
spectra for each measurement. All spectra were recorded at 25 °C. To study the influence of 
oxidation, 25 µM samples of reduced apo- or Zn2γ-Ec-1 in 10 mM NaCl, 10 mM Tris-HCl, pH 
7.5, were mixed with 2 mM (final concentration) H2O2, and the progress of the reaction 
monitored with CD spectra over time. 
 
Mass spectrometry 
Preparation of completely and partially oxidized γ-Ec-1 for MS analysis 
Completely oxidized γ-Ec-1 was prepared as described above by overnight oxidation of 
Zn2γ-Ec-1 with 2 mM H2O2. After dialysis and digestion with trypsin (see below) MS-MS 
analysis was performed. 
Partially oxidized Zn1γ-Ec-1 was obtained by incubation of 20 µM Zn2γ-Ec-1 in 10 mM 
ammonium acetate, pH 7.5, with 1.5 mM H2O2 and control of the oxidation state at certain time 
intervals, i.e. 15, 50, and 120 min. The respective amount of reduced Cys residues was 
determined with the 2-PDS assay and the amount of remaining coordinated Zn(II) ions was 
measured with F-AAS after removal of loosely bound or released Zn(II) ions with Chelex 100 
resin. Two sample aliquots from each time point, one of them after modification with 
iodoacetamide and trypsin digestion (see below), were subjected to MS-MS analysis (see below). 
 
Modification with iodoacetamide 
20 µL of a 20 µM γ-Ec-1 solution were mixed with a 10-fold molar excess of iodoacetamide 
and incubated for 40 min in the dark. The reaction was stopped by freezing in liquid nitrogen. 
The non-reacted iodoacetamide was removed by C18 ZipTip (Millipore, Billerica, MA, USA) 
directly prior to MS measurements.     
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Trypsin digest  
0.1 µg trypsin in 20 µL Tris-HCl, pH 5, was added to 10 µL of the respective protein 
solution (total amount 0.5 µg) in 10 mM ammonium acetate buffer, pH 7.5, and digestion was 
performed at rt for 90 min. The conditions, especially the low pH and temperature, were chosen 
to avoid scrambling of the disulfide bonds formed after initial oxidation of the protein. The 
resulting peptide digest mixture was desalted using a C18 ZipTip and spotted onto the MALDI 
target (MTP 384 target polished steel TF, Bruker Daltonics, Bremen, Germany) with 1:10 
HPBA/CHCA in 50:50:0.1 ACN/H2O/TFA (5 µg/ µL) for subsequent MALDI-TOF/TOF 
measurements. 
 
MALDI-TOF/TOF measurement 
MALDI measurements of trypsin digested samples were performed on an ultrafleXtreme 
MALDI-TOF/TOF mass spectrometer equipped with a smartbeam laser (Bruker Daltonics). The 
measurement parameters were programmed in flexControl (Version 3.4): laser frequency of 1000 
Hz in the positive reflectron mode with acquisition ranging from 700 to 4000 Da. Final spectra 
consisted of 1000-3000 shots per analysis. MS and MS/MS data of ions of interest were acquired 
manually. The mass spectrometer was calibrated in MS mode for every new digest; in the 
MS/MS mode, the precursor ion was used as the reference mass in the individual analysis.  
In order to prevent disulfide-bond reduction with CHCA during ionization, a 1:10 mixture 
of HBPA/CHCA was used; HBPA protects disulfides from reduction by being reduced 
preferentially.60  Peptide fragments that are connected by disulfide bridges were identified using 
a high energy fragmentation technique. For this, MS/MS data were acquired using MALDI LIFT 
TOF/TOF mass spectrometry in the positive ion mode. The fragmentation was induced by the 
smartbeam laser without the further use of collision gas. Precursor ions were then accelerated 
and selected in the timed ion gate. In the LIFT cell the fragment ions were further accelerated 
and the MS/MS data recorded.  
 
Electrospray-ionization mass spectrometry 
Samples of Zn2- or apo- (reduced or oxidized) γ-Ec-1  in 10 mM NH4HCO3, pH 7.0, or 2 
mM HCl depending on downstream experiments were injected directly or with a prior 
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acidification step into an Synapt G2 quadrupole time-of-flight spectrometer (Waters, UK). For 
analysis at neutral pH 10 mM NH4Ac in 50% MeOH, pH 7.5, was used, at acidic pH 50% ACN 
and 0.2% formic acid, pH 2–3, (final concentrations) were added. Scans were accumulated and 
further processed with the software MassLynx 3.5 (Micromass). Deconvolution of MS data was 
done by applying the maximum entropy algorithm of the MassLynx tool MaxEnt1. Electrospray 
parameters were capillary voltage 2.6 V, cone voltage 50 V, and source temperature 80 °C. 
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FIGURE LEGENDS 
 
FIGURE 1  Scheme of proposed interchange mechanisms between different MT forms found in 
the plant cell (abbreviations used: ROS/RNS, reactive oxygen/nitrogen species; Grx, 
glutaredoxin; GSR, glutathione-disulfide reductase; Trx, thioredoxin; TR, thioredoxin reductase). 
A metal chelator can be any compound, e.g. apo-proteins or small molecules, with a metal ion 
binding affinity similar to or higher than the one of the respective MT. 
 
FIGURE 2  Schematic presentation of different conditions used for the oxidation of apo- and 
Zn2γ-Ec-1 and the resulting species. 
 
FIGURE 3  Oxidation of 10 µM Zn2γ-Ec-1 with 2 mM H2O2. (A) Time dependent evolution of 
absorption spectra. The absorption range 255-310 nm is marked with a box and enlarged in (B). 
(B) Enlarged absorption range 255-310 nm, after subtraction of the initial Zn2γ-Ec-1 spectrum 
from all other spectra, showing the evolution of a broad absorption band originating from 
disulfide bridge formation. (C) Plot of time dependent absorptivity changes at 230 (black 
squares, right axis) and 280 nm (grey open squares, left axis). The decrease in absorption at 230 
nm results from Zn(II) release from the metal-thiolate cluster, the appearance of the broad 
absorption band centered at 280 nm is indicative for disulfide bridge formation. Below the graph 
the hypothetical species present at 50, 75, and 100% Zn(II) release are given (see text for 
discussion). 
 
FIGURE 4  Oxidation of 10 µM Zn2γ-Ec-1 with 2 mM H2O2 in presence of 100 µM zincon 
leading to formation of the Zn(II)-zincon complex. (A) Plot of the Zn(II)-zincon complex 
absorption at 620 nm against incubation time. (B) Plot of ln((Astart-At)/(Astart-Aend)) against time 
(black dots) for the determination of the first-order rate constants (k) of Zn(II) release from 
Zn2γEc-1 with equation 1. The linear fits for the different time ranges are depicted as dashed lines 
and result in the following values: 0-50 min (= 25% ZnII release), k1 = (6.63 ± 0.97) · 10
-4 s-1; 50-
110 min (= 50% ZnII release), k2 = (1.88 ± 0.11) · 10
-4 s-1; 110-190 min (= 75% ZnII release), k3 
= (0.78 ± 0.04) · 10-4 s-1; 190-380 min (= 100% ZnII release), k4 = (0.22 ± 0.02) · 10
-4 s-1; 0-380 
min, kav = (0.97 ± 0.14) · 10
-4 s-1 . 
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FIGURE 5  CD spectra taken at different time points (see legend) during the oxidation of 25 µM 
solutions of Zn2γ-Ec-1 (black) or reduced apo-γ-Ec-1 (grey) with 2 mM H2O2. Ellipticity values 
below approximately 210 nm (grey box) are not reliable due to saturation of the CD detector at 
the protein concentration used. 
 
FIGURE 6  (A) Amino acid sequence alignment of the γ-Ec-1 domain with the sequence of the 
cyclic MCoTI-II protein (PDB ID: 1IB9) revealing a sequence identity of 32 % (marked with *) 
and a sequence similarity of 44 % (marked with .; Clustal Omega server, 
http://www.ebi.ac.uk/Tools/msa/clustalo/). The disulfide bridge connectivities determined for 
MCoTI-II are indicated above the sequence.53 (B) Solution structure of Zn2γEc-1 (2L61) obtained 
by NMR spectroscopy with cysteine sulfur atoms depicted as white balls and Zn(II) ions as grey 
spheres. The disulfide connectivities predicted by mass spectrometry are indicated by dashed 
lines. (C) Amino acid sequence of γ-Ec-1 with proposed disulfide connectivities based on the MS 
data. 
 
FIGURE 7  Species observed in the MS data during the oxidation of Zn2γ-Ec-1 with H2O2. 
Zn(II) ions are shown as green spheres, reduced Cys residues as black and oxidized Cys as 
orange circles, disulfide bridges are depicted with an orange and Zn-S bonds with a grey line. 
The predicted position of the remaining Zn(II) ion in the partially oxidized Zn1γ-Ec-1 form is 
indicated by a green sphere and a “?”. The backbone of the peptide fragments observed with MS 
is colored black, while the rest of the backbone is grey. 
 
FIGURE 8  (A) Amino acid sequence of the γ-Ec-1 domain with potential proteinase K cleavage 
sites indicated. Size exclusion chromatograms of 40 µM solutions of (B) Zn2-, (C) reduced, and 
(D) oxidized apo-γ-Ec-1 prior (black dashed lines) and after (black solid lines) incubation with 
proteinase K in a molar ratio of 5:1. The chromatogram of a control solution containing only 
proteinase K is depicted as a grey dotted line in each part. The peptide fragments observed in the 
MS data of the main peaks marked with * are given below each chromatogram. For details on 
MS data assignment see Figure S23, Supporting Information. In addition, oxidized γ-Ec-1 was 
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also incubated with a 5-times higher amount of proteinase K (1:1 molar ratio, black thin line in 
(D)), however, the peak corresponding to full length γ-Ec-1 is still detected. 
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Figure 1. Scheme of proposed interchange mechanisms between different MT forms found in the plant cell 
(abbreviations used: ROS/RNS, reactive oxygen/nitrogen species; Grx, glutaredoxin; GSR, glutathione-
disulfide reductase; Trx, thioredoxin; TR, thioredoxin reductase). A metal chelator can be any compound, 
e.g. apo-proteins or small molecules, with a metal ion binding affinity similar to or higher than the one of 
the respective MT.  
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Figure 2. Schematic presentation of different conditions used for the oxidation of apo- and Zn2γ-Ec-1 and the 
resulting species.  
77x103mm (300 x 300 DPI)  
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Figure 3. Oxidation of 10 µM Zn2γ-Ec-1 with 2 mM H2O2. (A) Time dependent evolution of absorption spectra. 
The absorption range 255-310 nm is marked with a box and enlarged in (B). (B) Enlarged absorption range 
255-310 nm, after subtraction of the initial Zn2γ-Ec-1 spectrum from all other spectra, showing the evolution 
of a broad absorption band originating from disulfide bridge formation. (C) Plot of time dependent 
absorptivity changes at 230 (black squares, right axis) and 280 nm (grey open squares, left axis). The 
decrease in absorption at 230 nm results from Zn(II) release from the metal-thiolate cluster, the 
appearance of the broad absorption band centered at 280 nm is indicative for disulfide bridge formation. 
Below the graph the hypothetical species present at 50, 75, and 100% Zn(II) release are given (see text for 
discussion).  
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Figure 4. Oxidation of 10 µM Zn2γ-Ec-1 with 2 mM H2O2 in presence of 100 µM zincon leading to formation of 
the Zn(II)-zincon complex. (A) Plot of the Zn(II)-zincon complex absorption at 620 nm against incubation 
time. (B) Plot of ln((Astart-At)/(Astart-Aend)) against time (black dots) for the determination of the first-order 
rate constants (k) of Zn(II) release from Zn2γEc-1 with equation 1. The linear fits for the different time 
ranges are depicted as dashed lines and result in the following values: 0-50 min (= 25% Zn(II) release), k1 
= (6.63 ± 0.97) • 10-4 s-1; 50-110 min (= 50% Zn(II) release), k2 = (1.88 ± 0.11) • 10
-4 s-1; 110-190 min 
(= 75% Zn(II) release), k3 = (0.78 ± 0.04) • 10
-4 s-1; 190-380 min (= 100% Zn(II) release), k4 = (0.22 ± 
0.02) • 10-4 s-1; 0-380 min, kav = (0.97 ± 0.14) • 10
-4 s-1 .  
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Figure 5. CD spectra taken at different time points (see legend) during the oxidation of 25 µM solutions of 
Zn2γ-Ec-1 (black) or reduced apo-γ-Ec-1 (grey) with 2 mM H2O2. Ellipticity values below approximately 210 
nm (grey box) are not reliable due to saturation of the CD detector at the protein concentration used.  
126x93mm (300 x 300 DPI)  
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Figure 6. (A) Amino acid sequence alignment of the γ-Ec-1 domain with the sequence of the cyclic MCoTI-II 
protein (PDB ID: 1IB9) revealing a sequence identity of 32 % (marked with *) and a sequence similarity of 
44 % (marked with .; Clustal Omega server, http://www.ebi.ac.uk/Tools/msa/clustalo/). The disulfide 
bridge connectivities determined for MCoTI-II are indicated above the sequence.53 (B) Solution structure of 
Zn2γEc-1 (2L61) obtained by NMR spectroscopy with cysteine sulfur atoms depicted as white balls and Zn(II) 
ions as grey spheres. The disulfide connectivities predicted by mass spectrometry are indicated by dashed 
lines. (C) Amino acid sequence of γ-Ec-1 with proposed disulfide connectivities based on the MS data.  
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Figure 7. Species observed in the MS data during the oxidation of Zn2γ-Ec-1 with H2O2. Zn(II) ions are 
shown as green spheres, reduced Cys residues as black and oxidized Cys as orange circles, disulfide bridges 
are depicted with an orange and Zn-S bonds with a grey line. The predicted position of the remaining Zn(II) 
ion in the partially oxidized Zn1γ-Ec-1 form is indicated by a green sphere and a “?”. The backbone of the 
peptide fragments observed with MS is colored black, while the rest of the backbone is grey.  
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Figure 8.  (A) Amino acid sequence of the γ-Ec-1 domain with potential proteinase K cleavage sites 
indicated. Size exclusion chromatograms of 40 µM solutions of (B) Zn2-, (C) reduced, and (D) oxidized apo-
γ-Ec-1 prior (black dashed lines) and after (black solid lines) incubation with proteinase K in a molar ratio of 
5:1. The chromatogram of a control solution containing only proteinase K is depicted as a grey dotted line in 
each part. The peptide fragments observed in the MS data of the main peaks marked with * are given below 
each chromatogram. For details on MS data assignment see Figure S23, Supporting Information. In 
addition, oxidized γ-Ec-1 was also incubated with a 5-times higher amount of proteinase K (1:1 molar ratio, 
black thin line in (D)), however, the peak corresponding to full length γ-Ec-1 is still detected.  
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